INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Hospital de Clínicas de Porto Alegre
Porto Alegre, BrasilPublicaciones en colaboración con investigadores/as de Hospital de Clínicas de Porto Alegre (6)
2023
-
Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170
Blood, Vol. 142, Núm. 2, pp. 141-145
2022
-
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Liver International, Vol. 42, Núm. 8, pp. 1891-1901
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2019
-
Pembrolizumab in relapsed or refractory primary mediastinal large b-cell lymphoma
Journal of Clinical Oncology
2018
-
Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder
Journal of Affective Disorders, Vol. 240, pp. 57-62
2017
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367